Presenilins interact with Rab11, a small GTPase involved in the regulation of vesicular transport

被引:87
作者
Dumanchin, C
Czech, C
Campion, D
Cuif, MH
Poyot, T
Martin, C
Charbonnier, F
Goud, B
Pradier, L
Frebourg, T
机构
[1] Fac Med & Pharm, INSERM, EPI 9906, F-76183 Rouen, France
[2] IFRMP, F-76821 Rouen, France
[3] Rhone Poulenc Rorer, Ctr Rech Vitry Alfortville, F-94403 Vitry, France
[4] Inst Curie, CNRS, Unite Mixte Rech 144, F-75248 Paris 05, France
关键词
D O I
10.1093/hmg/8.7.1263
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Presenilin 1 (PS1) mutations account for the majority of early-onset dominant cases of familial Alzheimer's disease. Presenilins (PSs) are located in many intracellular compartments such as the endoplasmic reticulum, Golgi apparatus, nuclear region and vesicular structures. These proteins include from seven to nine putative transmembrane domains, with the N- and C-terminal ends and a large hydrophilic loop orientated towards the cytoplasm. We report an interaction between the human PS1 or PS2 hydrophilic loop and Rab11, a small GTPase belonging to the Ras-related superfamily, Interaction domains were mapped to codons 374-400 for PS1 and to codons 106-179 for Rab11, a region including the fourth GTP-binding domain. Considering the implication of Rab proteins in vesicular transport pathways, the PS-Rab11 interaction suggests that PSs might be involved in amyloid precursor protein vesicular routing.
引用
收藏
页码:1263 / 1269
页数:7
相关论文
共 56 条
  • [1] alpha-secretase-derived product of beta-amyloid precursor protein is decreased by presenilin 1 mutations linked to familial Alzheimer's disease
    Ancolio, K
    Marambaud, P
    Dauch, P
    Checler, F
    [J]. JOURNAL OF NEUROCHEMISTRY, 1997, 69 (06) : 2494 - 2499
  • [2] Baumeister R, 1997, Genes Funct, V1, P149
  • [3] Immunohistochemical analysis of presenilin 2 expression in the mouse brain: Distribution pattern and co-localization with presenilin 1 protein
    Blanchard, V
    Czech, C
    Bonici, B
    Clavel, N
    Gohin, M
    Dalet, K
    Revah, F
    Pradier, L
    Imperato, A
    Moussaoui, S
    [J]. BRAIN RESEARCH, 1997, 758 (1-2) : 209 - 217
  • [4] Familial Alzheimer's disease-linked presenilin 1 variants elevate A beta 1-42/1-40 ratio in vitro and in vivo
    Borchelt, DR
    Thinakaran, G
    Eckman, CB
    Lee, MK
    Davenport, F
    Ratovitsky, T
    Prada, CM
    Kim, G
    Seekins, S
    Yager, D
    Slunt, HH
    Wang, R
    Seeger, M
    Levey, AI
    Gandy, SE
    Copeland, NG
    Jenkins, NA
    Price, DL
    Younkin, SG
    [J]. NEURON, 1996, 17 (05) : 1005 - 1013
  • [5] CAMPBELL RI, 1995, IEEE DES TEST COMPUT, V12, P4
  • [6] A novel presenilin 1 mutation resulting in familial Alzheimer's disease with an onset age of 29 years
    Campion, D
    Brice, A
    Dumanchin, C
    Puel, M
    Baulac, M
    delaSayette, V
    Hannequin, D
    Duyckaerts, C
    Michon, A
    Martin, C
    Moreau, V
    Penet, C
    Martinez, M
    ClergetDarpoux, F
    Agid, Y
    Frebourg, T
    [J]. NEUROREPORT, 1996, 7 (10) : 1582 - 1584
  • [7] Cataldo AM, 1997, J NEUROSCI, V17, P6142
  • [8] Rab11 is required for trans-Golgi network to plasma membrane transport and a preferential target for GDP dissociation inhibitor
    Chen, W
    Feng, Y
    Chen, DY
    Wandinger-Ness, A
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1998, 9 (11) : 3241 - 3257
  • [9] THE 2-HYBRID SYSTEM - A METHOD TO IDENTIFY AND CLONE GENES FOR PROTEINS THAT INTERACT WITH A PROTEIN OF INTEREST
    CHIEN, CT
    BARTEL, PL
    STERNGLANZ, R
    FIELDS, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (21) : 9578 - 9582
  • [10] Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice
    Citron, M
    Westaway, D
    Xia, WM
    Carlson, G
    Diehl, T
    Levesque, G
    JohnsonWood, K
    Lee, M
    Seubert, P
    Davis, A
    Kholodenko, D
    Motter, R
    Sherrington, R
    Perry, B
    Yao, H
    Strome, R
    Lieberburg, I
    Rommens, J
    Kim, S
    Schenk, D
    Fraser, P
    Hyslop, PS
    Selkoe, DJ
    [J]. NATURE MEDICINE, 1997, 3 (01) : 67 - 72